Evidence map›Paper›PMID 23434634›Full record

ReviewJournal of lipid research2013

Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond.

Amy S Shah, Lirong Tan, Jason Lu Long, W Sean Davidson

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of lipid research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 192 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
192citing papers in PubMed, 1 pooled it
22.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

192 citing papers in PubMed, 1 synthesis or guideline pooled it, 351 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Review
  15. Article
  16. Article
  17. Article
  18. Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics.Journal of cardiovascular development and disease · 2025
    Review
  19. Review
  20. Article

132 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Amy S ShahDivision of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Lirong Tan
Jason Lu Long
W Sean Davidson
Cincinnati Children's Hospital Medical Center · USUniversity of Cincinnati · US

Funding

Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E. · 2012 to 2014
$9.9M
A Network-based Approach to Associate HDL Subspeciation with FunctionR01HL111829 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI LU, LONG · 2012 to 2016
$2.6M
Understanding the Role of HDL Subspecies in Adolescents with Type 2 DiabetesK23HL118132 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI SHAH, AMY SANGHAVI · 2014 to 2018
$855k
NCATS NIH HHS UL1 TR000077NHLBI NIH HHS K23 HL118132NHLBI NIH HHS R01 HL111829
6 · The paper itself

Abstract

Recent applications of mass spectrometry technology have dramatically increased our understanding of the proteomic diversity of high density lipoproteins (HDL). Depending on the method of HDL isolation, upwards of 85 proteins have been identified, and the list continues to grow. In addition to proteins consistent with traditionally accepted roles in lipid transport, HDL carries surprising constituents, such as members of the complement pathway, protease inhibitors involved in hemostasis, acute-phase response proteins, immune function mediators, and even metal-binding proteins. This compositional diversity fits well with hundreds of studies demonstrating a wide functional pleiotrophy, including roles in lipid transport, oxidation, inflammation, hemostasis, and immunity. This review summarizes the progression of our understanding of HDL proteomic complexity and points out key experimental observations that reinforce the functional diversity of HDL. The possibility of specific HDL subspecies with distinct functions, the evidence supporting this concept, and some of the best examples of experimentally defined HDL subspecies are also discussed. Finally, key challenges facing the field are highlighted, particularly the need to identify and define the function of HDL subspecies to better inform attempts to pharmacologically manipulate HDL for the benefit of cardiovascular disease and possibly other maladies.

Indexed as

Lipid MetabolismAnimalsCardiovascular DiseasesHumansLipoproteins, HDLMass SpectrometryProteomeProteomicsLipoproteins, HDLProteomeapolipoproteinscomplementfunctionhemostasisinflammationinnate immunitylipid metabolismmass spectrometryprotease inhibition

Identifiers

PMID23434634
PMCPMC3770071
OpenAlexW2054786421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.